Correlation Between Oasmia Pharmaceutical and Takeda Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Oasmia Pharmaceutical and Takeda Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oasmia Pharmaceutical and Takeda Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oasmia Pharmaceutical AB and Takeda Pharmaceutical Co, you can compare the effects of market volatilities on Oasmia Pharmaceutical and Takeda Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oasmia Pharmaceutical with a short position of Takeda Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oasmia Pharmaceutical and Takeda Pharmaceutical.
Diversification Opportunities for Oasmia Pharmaceutical and Takeda Pharmaceutical
0.59 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Oasmia and Takeda is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Oasmia Pharmaceutical AB and Takeda Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Takeda Pharmaceutical and Oasmia Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oasmia Pharmaceutical AB are associated (or correlated) with Takeda Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Takeda Pharmaceutical has no effect on the direction of Oasmia Pharmaceutical i.e., Oasmia Pharmaceutical and Takeda Pharmaceutical go up and down completely randomly.
Pair Corralation between Oasmia Pharmaceutical and Takeda Pharmaceutical
Assuming the 90 days horizon Oasmia Pharmaceutical AB is expected to generate 23.58 times more return on investment than Takeda Pharmaceutical. However, Oasmia Pharmaceutical is 23.58 times more volatile than Takeda Pharmaceutical Co. It trades about 0.0 of its potential returns per unit of risk. Takeda Pharmaceutical Co is currently generating about 0.0 per unit of risk. If you would invest 20.00 in Oasmia Pharmaceutical AB on August 29, 2024 and sell it today you would lose (14.00) from holding Oasmia Pharmaceutical AB or give up 70.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 8.48% |
| Values | Daily Returns |
Oasmia Pharmaceutical AB vs. Takeda Pharmaceutical Co
Performance |
| Timeline |
| Oasmia Pharmaceutical |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Takeda Pharmaceutical |
Oasmia Pharmaceutical and Takeda Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Oasmia Pharmaceutical and Takeda Pharmaceutical
The main advantage of trading using opposite Oasmia Pharmaceutical and Takeda Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oasmia Pharmaceutical position performs unexpectedly, Takeda Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Takeda Pharmaceutical will offset losses from the drop in Takeda Pharmaceutical's long position.| Oasmia Pharmaceutical vs. Ryanair Holdings PLC | Oasmia Pharmaceutical vs. LENSAR Inc | Oasmia Pharmaceutical vs. Cumberland Pharmaceuticals | Oasmia Pharmaceutical vs. Finnair Oyj |
| Takeda Pharmaceutical vs. Viatris | Takeda Pharmaceutical vs. Elanco Animal Health | Takeda Pharmaceutical vs. Zoetis Inc | Takeda Pharmaceutical vs. Emergent Biosolutions |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |